Latest Breaking News On - Nathalie altermatt - Page 18 : comparemela.com

Roche enters partnership with Alnylam to co-develop and co-commercialise RNAi therapeutic zilebesiran to treat hypertension in patients with high cardiovascular risk

Roche enters partnership with Alnylam to co-develop and co-commercialise RNAi therapeutic zilebesiran to treat hypertension in patients with high cardiovascular risk
itbusinessnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from itbusinessnet.com Daily Mail and Mail on Sunday newspapers.

United statesBruno eschliNathalie altermattYvonne greenstreet mbchKirti pandeyTeresa grahamLoren kalmGerard tobinRoche pharmaBirgit masjostSabine borngrWorld health organizationRoche groupRoche group media relationsB circulation researchYvonne greenstreet

CHMP recommends Roche s Evrysdi for babies under two months old with spinal muscular atrophy (SMA)

CHMP recommends Roche s Evrysdi for babies under two months old with spinal muscular atrophy (SMA)
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesUnited kingdomGerard tobinSabine borngrNathalie altermattKirti pandeyBirgit masjostLevi garrawayBruno eschliLoren kalmBritish pharmacological societyRoche group media relationsRoche groupEuropean medicines agencyDrug administrationEuropean union

F Hoffmann-La Roche Ltd: CHMP recommends Roche s Evrysdi for babies under two months old with spinal muscular atrophy (SMA)

F Hoffmann-La Roche Ltd: CHMP recommends Roche s Evrysdi for babies under two months old with spinal muscular atrophy (SMA)
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

United kingdomUnited statesKirti pandeySabine borngrLevi garrawayNathalie altermattBruno eschliGerard tobinBirgit masjostLoren kalmEuropean commissionOffice of orphan products developmentMuscular dystrophy association clinicalBritish pharmacological societyRoche group media relationsDrug administration

CHMP recommends Roche s Evrysdi for babies under two months old with spinal muscular atrophy (SMA)

CHMP recommends Roche s Evrysdi for babies under two months old with spinal muscular atrophy (SMA)
itbusinessnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from itbusinessnet.com Daily Mail and Mail on Sunday newspapers.

United statesUnited kingdomKirti pandeyBruno eschliGerard tobinLevi garrawayBirgit masjostLoren kalmSabine borngrNathalie altermattSociety for medicines researchHead of global product developmentEuropean commissionEuropean unionRoche groupDrug administration

New clinical and real-world data for Roche s Vabysmo at ASRS reveal improved outcomes for people with two leading causes of vision loss

Late-breaking post-hoc data indicate Vabysmo leads to less fibrosis, which may negatively impact vision, than aflibercept in people with diabetic macular edema Real-world data reinforce that.

United statesUnited kingdomCity ofLevi garrawayNathalie altermattBruno eschliBirgit masjostGerard tobinLoren kalmSabine borngrKirti pandeyRegulatory agencyNational eye instituteAmerican society of retina specialistsRoche group media relationsDrug administration